{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:39Z","timestamp":1790388219158,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10354-015-0361-x","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T07:50:20Z","timestamp":1433749820000},"page":"278-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Osteogenesis imperfecta: pathophysiology and treatment","Osteogenesis imperfecta: Update zu Pathophysiology und Therapie"],"prefix":"10.1007","volume":"165","author":[{"given":"Heike","family":"Hoyer-Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"issue":"9418","key":"361_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377\u201385.","journal-title":"Lancet"},{"issue":"2","key":"361_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/uog.6359","volume":"34","author":"T Schramm","year":"2009","unstructured":"Schramm T, et al. Prenatal sonographic diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol. 2009;34(2):160\u201370.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1988.tb55313.x","volume":"543","author":"BF Pontz","year":"1988","unstructured":"Pontz BF, Stoss H, Spranger J. Heterogeneity in osteogenesis imperfecta: clinical and morphological findings. Ann N Y Acad Sci. 1988;543:30\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"361_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2106\/JBJS.L.01596","volume":"96","author":"AK Anissipour","year":"2014","unstructured":"Anissipour AK, et al. Behavior of scoliosis during growth in children with osteogenesis imperfecta. J Bone Joint Surg Am. 2014;96(3):237\u201343.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"361_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-2008-1037397","volume":"137","author":"A Karbowski","year":"1999","unstructured":"Karbowski A, Schwitalle M, Eckardt A. [Scoliosis in patients with osteogenesis imperfecta: a federal nation-wide cross-sectional study]. Z Orthop Ihre Grenzgeb. 1999;137(3):219\u201322.","journal-title":"Z Orthop Ihre Grenzgeb"},{"issue":"Pt","key":"361_CR6","first-page":"191","volume":"104","author":"MI Kaiser-Kupfer","year":"1985","unstructured":"Kaiser-Kupfer MI, et al. Correlation of ocular rigidity and blue sclerae in osteogenesis imperfecta. Trans Ophthalmol Soc U K. 1985;104(Pt.\u00a02):191\u20135.","journal-title":"Trans Ophthalmol Soc U K"},{"issue":"Suppl","key":"361_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0973-029X.141363","volume":"18","author":"D Devaraju","year":"2014","unstructured":"Devaraju D, et al. Dentinogenesis imperfecta type I: a case report with literature review on nomenclature system. J Oral Maxillofac Pathol. 2014;18(Suppl.\u00a01):131\u20134.","journal-title":"J Oral Maxillofac Pathol"},{"key":"361_CR8","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini JC, Blissett AR. New genes in bone development: what\u02bcs new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013;98:3095\u2013103.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"361_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","volume":"91","author":"O Semler","year":"2012","unstructured":"Semler O, et al. A mutation in the 5\u02b9-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet. 2012;91(2):349\u201357.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"361_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","volume":"91","author":"TJ Cho","year":"2012","unstructured":"Cho TJ, et al. A single recurrent mutation in the 5\u02b9-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet. 2012;91(2):343\u20138.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"361_CR11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15(9):1650\u20138.","journal-title":"J Bone Miner Res"},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/jbmr.2173","volume":"29","author":"CR Farber","year":"2014","unstructured":"Farber CR, et al. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res. 2014;29:1402\u201311.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"361_CR13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011;88(3):362\u201371.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"361_CR14","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2012-1827","volume":"97","author":"F Rauch","year":"2012","unstructured":"Rauch F, et al. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab. 2012;97(8):E1550\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"361_CR15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2005.10.041","volume":"148","author":"C Land","year":"2006","unstructured":"Land C, et al. Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta. J Pediatr. 2006;148(4):456\u201360.","journal-title":"J Pediatr"},{"issue":"3","key":"361_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000075589","volume":"61","author":"Z Sumnik","year":"2004","unstructured":"Sumnik Z, et al. Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry. Horm Res. 2004;61(3):137\u201342.","journal-title":"Horm Res"},{"issue":"14","key":"361_CR17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339(14):947\u201352.","journal-title":"N Engl J Med"},{"issue":"5","key":"361_CR18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, et al. Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res. 2005;20(5):758\u201363.","journal-title":"J Bone Miner Res"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00774-011-0331-3","volume":"30","author":"E Maines","year":"2011","unstructured":"Maines E, et al. Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. J Bone Miner Metab. 2011;30:434\u20138.","journal-title":"J Bone Miner Metab"},{"issue":"9902","key":"361_CR20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","volume":"382","author":"N Bishop","year":"2013","unstructured":"Bishop N, et al. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382(9902):1424\u201332.","journal-title":"Lancet"},{"issue":"1","key":"361_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-014-0145-1","volume":"9","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, et al. Two years experience with denosumab for children with Osteogenesis imperfecta type VI. Orphanet J Rare Dis. 2014;9(1):145.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"361_CR22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll ES, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest. 2014;124(2):491\u20138.","journal-title":"J Clin Invest"},{"issue":"5","key":"361_CR23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00223-013-9770-2","volume":"93","author":"D Gatti","year":"2013","unstructured":"Gatti D, et al. Teriparatide treatment in adult patients with osteogenesis imperfecta type I. Calcif Tissue Int. 2013;93(5):448\u201352.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"361_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, et al. Bone neoplasms in F344 rats given teriparatide [rhPTH(1\u201334)] are dependent on duration of treatment and dose. Toxicol Pathol. 2004;32(4):426\u201338.","journal-title":"Toxicol Pathol"},{"issue":"8","key":"361_CR25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1055\/s-0032-1312833","volume":"184","author":"F Koerber","year":"2012","unstructured":"Koerber F, et al. Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta. Rofo. 2012;184(8):719\u201325.","journal-title":"Rofo"},{"issue":"9","key":"361_CR26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00132-012-1959-y","volume":"41","author":"T Wirth","year":"2012","unstructured":"Wirth T, [Osteogenesis imperfecta]. Orthopade. 2012;41(9):773\u201382; quiz 83\u20134.","journal-title":"Orthopade"},{"issue":"2","key":"361_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2008-1072339","volume":"10","author":"A Karbowski","year":"2000","unstructured":"Karbowski A, et al. Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta. Eur J Pediatr Surg. 2000;10(2):119\u201324.","journal-title":"Eur J Pediatr Surg"},{"issue":"3","key":"361_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11832-011-0341-7","volume":"5","author":"J Ruck","year":"2011","unstructured":"Ruck J, et al. Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop. 2011;5(3):217\u201324.","journal-title":"J Child Orthop"},{"issue":"4","key":"361_CR29","first-page":"445","volume":"14","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, et al. A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J Musculoskelet Neuronal Interact. 2014;14(4):445\u201353.","journal-title":"J Musculoskelet Neuronal Interact"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-015-0361-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-015-0361-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-015-0361-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:11:10Z","timestamp":1559146270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-015-0361-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":29,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s10354-015-0361-x","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,9]]}}}